Literature DB >> 8956302

Serum erythropoietin and erythropoiesis during six years after kidney transplantation.

J Goch1, G Birgegård, B Wikström, U Backman, J Wadström, B G Danielson.   

Abstract

We have studied serum erythropoietin (EPO) levels during 6 years after kidney transplantation in 16 patients. There was a serum EPO peak around 50 mU/ml after 5 weeks. After 3 months the serum EPO level stabilized at around 30 mU/ml. Patients with good transplant function had significantly higher serum EPO levels and normalized their hemoglobin (Hb) after a mean of 3 months. If transplant function was good, Hb was normalized even if the serum EPO was only slightly elevated. Patients with poor transplant function had lower serum EPO and Hb levels. We concluded that a good transplant function is the key to a normal erythropoiesis and that small amounts of EPO are needed to improve Hb.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8956302     DOI: 10.1159/000189475

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  2 in total

1.  The pharmacokinetic profile of recombinant human erythropoietin is unchanged in patients undergoing cardiac surgery.

Authors:  Stuart A McCluskey; Wing K Cheung; Rita Katznelson; Humara Poonawala; Ludwik Fedorko; George Djaiani; Bobby Mehta; Keyvan Karkouti
Journal:  Eur J Clin Pharmacol       Date:  2008-10-30       Impact factor: 2.953

Review 2.  Fount, fate, features, and function of renal erythropoietin-producing cells.

Authors:  Sophie L Dahl; Andreas M Bapst; Stellor Nlandu Khodo; Carsten C Scholz; Roland H Wenger
Journal:  Pflugers Arch       Date:  2022-06-24       Impact factor: 4.458

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.